Voleon Capital Management’s Avadel Pharmaceuticals AVDL Stock Holding History

Voleon Capital Management’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-153,607	Closed	-$3.31M	–	796
2025 Q4	$3.31M	Buy	+153,607	New	+$2.98M	0.07%	255

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Voleon Capital Management's AVDL Position: Q1 2026 in Review

Voleon Capital Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 153,607 shares — an estimated $3.31M sold.

Voleon Capital Management first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $3.31M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

Voleon Capital Management reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Voleon Capital Management sold 153,607 Avadel Pharmaceuticals shares in Q1 2026, an estimated $3.31M.
Voleon Capital Management first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
Voleon Capital Management's Avadel Pharmaceuticals position peaked at $3.31M in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Voleon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.